Globus Medical, Inc. GMED
Updated: 11 Aug 2026
No signal published yet
We already track Globus Medical and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Globus Medical, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Globus Medical free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 6, 2026, Globus Medical reported its second-quarter financial results, generating worldwide net sales of $789.6 million, up 5.9% year-over-year. GAAP net income for the quarter reached $151.6 million, with non-GAAP diluted earnings per share rising 55.8% to $1.34. Following the strong performance, management raised its full-year 2026 non-GAAP diluted earnings per share guidance to between $4.95 and $5.05.
What Firelda Watch includes for Globus Medical, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Globus Medical, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Globus Medical free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more